Abstract
Group I metabotropic glutamate receptors mediate slow excitatory neurotransmission in the central nervous system and are critical to activity-dependent synaptic plasticity, a cellular substrate of learning and memory. Dysregulated receptor signaling is implicated in neuropsychiatric conditions ranging from neurodevelopmental to neurodegenerative disorders. Importantly, group I metabotropic glutamate receptor signaling functions can be modulated by interacting proteins that mediate receptor trafficking, expression and coupling efficiency to signaling effectors. These interactions afford cell-or pathway-specific modulation to fine-tune receptor function, thus representing a potential target for pharmacological interventions in pathological conditions.
Original language | English (US) |
---|---|
Pages (from-to) | 494-503 |
Number of pages | 10 |
Journal | Current Neuropharmacology |
Volume | 14 |
Issue number | 5 |
DOIs | |
State | Published - Jul 1 2016 |
Keywords
- Amyloid-β
- CaMKII α
- Caveolin-1
- Homer
- Norbin
- PrP
- Synaptic plasticity
- mGluR
ASJC Scopus subject areas
- Pharmacology
- Neurology
- Clinical Neurology
- Psychiatry and Mental health
- Pharmacology (medical)